HIGHLIGHTS
- who: Bruceu0092 and collaborators from the Frontiers Media SA, SwitzerlandSchool, Monash University, Melbourne, VIC, Australia, Department of Clinical Pathology, The have published the article: Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2, in the Journal: (JOURNAL)
SUMMARY
"FcgR and complement dependent effector functions of the ACE2-Fc decoy proteins. (A) Activation of FcgRIIIa by ACE2-Fc proteins. ACE2-Fc proteins activated FcgRIIIa, except for the Fc H429Y mutants which failed to stimulate in any ACE2 format either as oligomeric or monomeric forms. Ramos-S target cells were opsonized . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.